Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Nereus gets $23.6mm in private financing round

Executive Summary

Nereus Pharmaceuticals (drugs from marine microorganisms to treat infectious diseases, cancer, and inflammation) completed a second round of financing, raising $23.6mm from lead investor Pacific Venture Group; new investors Novartis Bioventure, Blue Dot Capital, China Development Industrial Bank, Lotus Biosciences, and Swissfirst; and return investors Alta Partners, Forward Ventures, GIMV, Jafco, and Tech Amp International.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies